Details for Patent: 9,447,089

Which drugs does patent 9,447,089 protect, and when does it expire?

Patent 9,447,089 protects ZELBORAF and is included in one NDA.

This patent has seventy-one patent family members in forty-two countries.

Summary for Patent: 9,447,089

Title:	Compositions and uses thereof
Abstract:	Provided are solid dispersions, solid molecular complexes, salts and crystalline polymorphs involving propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluor- o-phenyl}-amide.
Inventor(s):	Desai; Dipen (Whippany, NJ), Diodone; Ralph (Breisach, DE), Go; Zenaida (Clifton, NJ), Ibrahim; Prabha N. (Mountain View, CA), Iyer; Raman (Piscataway, NJ), Mair; Hans-Juergen (Loerrach, DE), Sandhu; Harpreet K. (West Orange, NJ), Shah; Navnit H. (Clifton, NJ), Visor; Gary (Castro Valley, CA), Wyttenbach; Nicole (Sissach, CH), Lauper; Stephan (Kaiseraugst, CH), Pudewell; Johannes (Oberwil, CH), Wierschem; Frank (Rheinfelden, CH)
Assignee:	Plexxikon Inc. (Berkeley, CA) Hoffman-La Roche Inc. (Nutley, NJ)
Application Number:	12/752,035
Patent Claim Types: see list of patent claims	Compound; Formulation; Dosage form; Composition;

Drugs Protected by US Patent 9,447,089

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Hoffmann La Roche	ZELBORAF	vemurafenib	TABLET;ORAL	202429-001	Aug 17, 2011		RX	Yes	Yes			Y

Foreign Priority and PCT Information for Patent: 9,447,089

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	09175665	Nov 11, 2009

International Family Members for US Patent 9,447,089

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	078033
Argentina	121037
Australia	2010232670
Australia	2010318049
Australia	2015238857
Brazil	112012009609